Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Interscalene block versus serratus posterior superior intercostal plane block for pain after arthroscopic shoulder surgery

Official title: Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block on Postoperative Analgesia Management After Arthroscopic Shoulder Surgery: A Randomized Prospective Study

Run by Medipol University · NCT07278050 · Data updated 2026-11-12

This will test whether a newer serratus posterior superior intercostal plane block works as well as the standard interscalene block for people having arthroscopic shoulder surgery.

More Shoulder Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment60 (estimated)
SponsorMedipol University
Academic / other
Locations1 site (Istanbul, Bagcilar)
StatusRecruiting
StartedJanuary 10, 2026
Main results expectedSeptember 20, 2026
Study endsOctober 25, 2026
Registry record updatedJanuary 14, 2026
Trial IDNCT07278050 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients with ASA physical status I–II who are scheduled for arthroscopic shoulder surgery under general anesthesia and who agree to receive a peripheral nerve block.

Probably not a fit

Patients with bleeding disorders, on anticoagulant therapy, allergic to local anesthetics or opioids, with skin infection at the injection site, who are pregnant or breastfeeding, or who decline the procedure are not likely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional comparison examines two ultrasound-guided regional anesthesia techniques — the commonly used interscalene brachial plexus block (ISCB) and the newer serratus posterior superior intercostal plane block (SPSPB) — for managing postoperative pain after arthroscopic shoulder surgery. Adults with ASA I–II scheduled for arthroscopic shoulder procedures under general anesthesia will receive one of the blocks perioperatively, with postoperative analgesia management and monitoring. The SPSPB involves injection at the serratus posterior superior muscle around the 2nd–3rd ribs to block lower cervical and upper intercostal nerves, while ISCB targets the brachial plexus at the interscalene level; both are performed under ultrasound guidance. Outcomes include postoperative pain, opioid consumption, time to mobilization, adverse events, and length of hospital stay.

Why it matters

Potential benefit: If successful, the SPSPB could provide effective postoperative shoulder pain relief with reduced opioid use and potentially fewer block-related complications.

How similar studies have gone: The interscalene block is well established and effective for shoulder analgesia, while the SPSPB is a novel block first described in 2023 and has limited published outcome data so far.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* American Society of Anesthesiologists (ASA) classification I-II
* Scheduled for arthroscopic shoulder surgery under general anesthesia

Exclusion Criteria:

* history of bleeding diathesis,
* receiving anticoagulant treatment,
* known local anesthetics and opioid allergy,
* infection of the skin at the site of the needle puncture,
* pregnancy or lactation,
* patients who do not accept the procedure

Where it's running

  • Istanbul Medipol University Hospital
    Istanbul, Bagcilar, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.